Table 1.
Cohort Clinical Characteristics
| n=39 | |
|---|---|
| EGA, mean ± SD | 27.6 ± 2.1 weeks |
| BW, mean ± SD | 1139 ± 286 g |
| Male sex, n (%) | 12 (31%) |
| Race, n (%) | |
| African-American | 15 (39%) |
| Caucasian | 24 (61%) |
| Antenatal steroids, n (%) | |
| Any | 25 (64%) |
| Complete | 20 (51%) |
| Cesarean delivery, n (%) | 28 (72%) |
| Delayed cord clamping, n (%) | 11 (29%) |
| 5 minute Apgar, median (range) | 6 (1-9) |
| CRIB-II score, median (range) | 9 (3-15) |
| Small for gestational age1, n (%) | 2 (5%) |
| Anemia during monitoring, n (%) | |
| Hemoglobin ≤8 g/dL | 6 (15%) |
| Hemoglobin ≤10 g/dL | 27 (69%) |
| Transfused, n (%) | 15 (39%) |
| Intraventricular hemorrhage, n (%) | 12 (31%) |
| Inotropic medications, n (%) | 2 (5%) |
| PDA treatment, n (%) | 5 (13%) |
| Necrotizing enterocolitis, n (%) | 1 (3%) |
| Bronchopulmonary dysplasia, n (%) | 17 (46%) |
| Mortality, n (%) | 1 (3%) |
1
Defined as BW <10th percentile.